Project Grant HT94252510667
Award Date
9/1/25
Completion Date
8/31/29
Dollars Obligated
$3.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94121, USA
Similar Awards
This $481,056.00 Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research at the University of California, Davis focused on investigating the role of the ARHGEF2 gene in prostate cancer treatment resistance and neural lineage plasticity. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing the understanding of prostate...
The federal Project Grant award of $2,136,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is focused on "REVERSIBILITY AND THERAPEUTIC TARGETING OF TREATMENT- EMERGENT NEUROENDOCRINE PROSTATE CANCER" and will be performed by the Dana-Farber Cancer Institute, Inc. (Dfci) located in Boston, MA. The grant supports advanced biomedical research aimed at transforming healthcare for military service members,...
The federal Project Grant award of $1,198,659.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program will fund research at Northwestern University to evaluate disparities and improve the quality of prostate cancer detection for veterans through imaging. The award, which runs from July 1, 2025 to June 30, 2029, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public....
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
The federal Project Grant award, valued at $1,312,000.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support research strategies to upregulate and image Nectin4 to enhance Nectin4-targeted therapies in bladder cancer. The research, to be conducted by The Regents of the University of California, San Francisco (UCSF) from August 1, 2025 to July 31, 2029, aims to transform healthcare for military service members, veterans,...
This federal Project Grant award of $2,028,000.00, awarded on April 1, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at identifying epigenetically driven vulnerabilities in metastatic castration-resistant prostate cancer. The award was granted to the Icahn School of Medicine at Mount Sinai, a prominent academic medical center and research institution in New York City. Through this...
The Defense Health Agency awarded a $468,000 Project Grant to the University of California, Los Angeles under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research developing new therapeutic strategies to target TROP2 in aggressive prostate cancer. The two-year award beginning March 15, 2023 will fund research efforts to investigate medical solutions for prostate cancer on the battlefield and transform health care for service members and the public...
This federal Project Grant award of $999,999.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research into cell-free DNA epigenetic biomarkers for multiple sclerosis. The award was granted on August 1, 2025 to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution. The project aims to transform healthcare for military service...
The Regents of the University of California, San Francisco was awarded a $1,202,954 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from April 1, 2022 to March 31, 2026 to improve informed decision-making for precision oncology in Veterans with advanced prostate cancer. Through basic, applied, and advanced biomedical research supported by this program, the...
The federal Project Grant award of $946,873.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research to investigate the genetic risk of prostate cancer in self-identified Black veterans. The award was granted to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a prominent private research university and academic medical center in Philadelphia. The research...